Cryofocus Medtech (Shanghai) Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-48.00
-120.00
-116.00
-137.00
-152.00
-179.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
13.00
-10.00
-20.00
-4.00
-9.00
12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-7.00
-90.00
-105.00
-112.00
-71.00
-36.00
Cash Flow from Investing Activities
0.00
-2.00
-16.00
-8.00
14.00
28.00
Cash Flow from Financing Activities
-2.00
28.00
-15.00
196.00
238.00
0.00
Net Cash Inflow / Outflow
-11.00
-62.00
-135.00
79.00
181.00
-8.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
1.00
1.00
3.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cryofocus Medtech (Shanghai) Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-48.213570968845
160.859759915692
-208.00
-129.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
13.7929682288504
85.45610351946
-72.00
-83.86%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-7.2847434811438
239.670988742734
-246.00
-103.04%
Cash Flow from Investing Activities
-0.835082995456422
-84.1948028393096
84.00
99.01%
Cash Flow from Financing Activities
-2.56055967827612
-68.0364891389132
66.00
96.24%
Net Cash Inflow / Outflow
-11.3072406631541
87.4396967645117
-98.00
-112.93%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.626854508277678
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 91.94% vs 14.63% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-7.28
-90.39
91.94%






